ABN AMRO Bank N.V.

Regulatory Filings • Mar 6, 2024

National Storage Mechanism | Additional information

RNS Number : 8679F

ABN Amro N.V.

06 March 2024

6 March 2024

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Argenta Spaarbank N.V.

Post-stabilisation Period Announcement

NO STABILISATION CARRIED OUT

Further to the pre-stabilisation period announcement dated 30 January 2024, ABN AMRO

Bank N.V. (contact: Hendrik Jan Onnes; +316 423 470 55) hereby gives notice that no

stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation

(EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the

Stabilisation Manager(s) named below in relation to the offer of the following securities.

The securities:
Issuer:	Argenta Spaarbank N.V.
Guarantor (if any):
Aggregate nominal amount:	EUR 750,000,000
Description:	Belgian Mortgage Pandbrieven due 2025 (BE6349638187)
Offer price:	99,249
Other offer terms:
Stabilisation:
Stabilising Manager(s):	ABN AMRO (B&D), LBBW, Natixis and NORD/LB
Stabilisation period expected to start on:	30 January 2024
Stabilisation period expected to end no later than:	06 March 2024
Maximum size of over-allotment facility:	5% of the aggregate nominal amount stated above.
Stabilisation Venue(s)	OTC

This announcement is for information purposes only and does not constitute an invitation

or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of

the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The

securities referred to above have not been, and will not be, registered under the United

States Securities Act of 1933 and may not be offered or sold in the United States absent

registration or an exemption from registration. There has not been and will not be a public

offer of the securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

STAUPUQAWUPCGWQ